Screener

Genedata Screener is a sophisticated platform designed to address challenges in assay screening by leveraging over 15 years of expertise in research IT and scientific analysis software. It is widely adopted by scientists and R&D professionals to enhance research efficiency and facilitate advancements.

Globally, leading pharmaceutical companies, contract research organizations (CROs), and academic research institutions rely on Genedata Screener to streamline discovery and development processes, reduce costs, and expedite decision-making.

AstraZeneca: Enhancing Discovery Efficiency

Prior to the implementation of Genedata Screener, AstraZeneca faced difficulties in standardizing data analysis across its research sites, each using different legacy systems for plate-based data analysis. This resulted in suboptimal data sharing and inconsistent analysis quality. The deployment of Genedata Screener in 2013 transformed AstraZeneca's operations by:

• Increasing data output and reporting within its corporate data warehouse.
• Facilitating advanced compound combination analysis.
• Standardizing analysis across various assay technologies and instruments, such as Biacore SPR instruments, Thermofluor, and DMPK analysis.

Genedata Screener has significantly contributed to making more preclinical data accessible to AstraZeneca's projects, reinforcing the company's leadership in drug discovery screening. The partnership between AstraZeneca and Genedata continues to thrive, with ongoing development of new analysis solutions, including those for high throughput mass spectrometry screening.

Further Success Stories

Explore additional success stories to see how Genedata Screener continues to advance discovery screening across the industry.